1 | Extended-release oxycodone | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬
|
2 | Oxycodone | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 6 6, 13, 70, 226, 298 💬
|
3 | Oxycodone Depot ”Sandoz”, depot tablets | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 298 298 💬
|
4 | OXYCODONE HYDROCHLORIDE | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 6 6, 70, 226, 298 💬
|
5 | Oxycodone naloxone prolonged release tablets | [2] Naloxone Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
6 | Oxycodone Orion | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
7 | Oxycodone/naloxone prolonged release t | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
8 | Oxycodone/Naloxone Prolonged Release tablets | [2] Naloxone Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
9 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
10 | Oxycodone/naloxone prolonged release tablets 10/5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
11 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
12 | Oxycodone/naloxone prolonged release tablets 20/10 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
13 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
14 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | [3] Manganese citrate Manganese citrate, Naloxone, Oxycodone | [2] Oxycodone
Oxycodone
,
Naloxone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 💬
|
15 | PR Oxycodone | [1] Oxycodone Oxycodone | [1] Oxycodone
Oxycodone
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|